Inc., the alternative asset manager, is reportedly considering the sale of Olympus Energy, according to Bloomberg News, ...
Olympus Partners has acquired PAI Pharma ("PAI"), the leading developer, manufacturer and distributor of generic oral liquids in both ready-to-dose cups and bottles in the United States. PAI offers ...
Olympus Partners has acquired PAI Pharma, a US-based manufacturer of generic oral liquids. No financial terms were disclosed. Kurt Orlofski serves as CEO of PAI. PAI Pharma has two large manufacturing ...
Asset manager Blackstone Group (BX) could be ready to switch off its investment in Olympus Energy. According to a Bloomberg report, Blackstone ...
The Food and Drug Administration on Friday confirmed a Class 1 recall of an Olympus reusable endoscope accessory tied to 120 injuries and one death, about six weeks after alerting the public that ...